Literature DB >> 2164731

Hepatitis delta virus RNA, protein synthesis and associated cytotoxicity in a stably transfected cell line.

T B Macnaughton1, E J Gowans, A R Jilbert, C J Burrell.   

Abstract

A trimer of hepatitis delta virus (HDV) cDNA in a retrovirus expression vector was transfected into subclone of the PLC/PRF/5 human hepatoma cell line, and a stable cell line (H1 delta 9) was clonally selected that supported the synthesis of both genomic and antigenomic sense HDV RNA. The H1 delta 9 cell line also expressed hepatitis delta antigen (HDAg) in cell nuclei in three distinct morphological patterns, including patterns typically seen in HDV-infected livers. HDAg expression was restricted to the smaller (p24) of the two HDAg-associated polypeptides in early passages of the H1 delta 9 cell line, but continuous passage of the cells resulted in increasing of expression of the larger (p27) HDAg-specific polypeptide. Passage of the H1 delta 9 cells also led to sustained expression of monomeric HDV RNA and a reduction in the levels of dimeric- and trimeric-HDV RNA. This was accompanied by an attenuation of virus-related cytotoxicity which was a feature of early cell passage numbers. HDV RNA replication in these cells was resistant to actinomycin D suggesting that replication was not dependent on continued expression from the transfected HDV cDNA and thus was likely to be self-sustaining.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2164731     DOI: 10.1016/0042-6822(90)90535-y

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  33 in total

1.  Genomic but not antigenomic hepatitis delta virus RNA is preferentially exported from the nucleus immediately after synthesis and processing.

Authors:  Thomas B Macnaughton; Michael M C Lai
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  Oligomerization of hepatitis delta antigen is required for both the trans-activating and trans-dominant inhibitory activities of the delta antigen.

Authors:  Y P Xia; M M Lai
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

3.  Structural requirements for RNA editing in hepatitis delta virus: evidence for a uridine-to-cytidine editing mechanism.

Authors:  J L Casey; K F Bergmann; T L Brown; J L Gerin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

4.  RNA-templated replication of hepatitis delta virus: genomic and antigenomic RNAs associate with different nuclear bodies.

Authors:  Yi-Jia Li; Thomas Macnaughton; Lu Gao; Michael M C Lai
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

5.  Large hepatitis delta antigen is a novel clathrin adaptor-like protein.

Authors:  Cheng Huang; Shin C Chang; I-Chen Yu; Yeou-Guang Tsay; Ming-Fu Chang
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

6.  Experimental transmission of human hepatitis delta virus to the laboratory mouse.

Authors:  H J Netter; K Kajino; J M Taylor
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

7.  Transcription of hepatitis delta antigen mRNA continues throughout hepatitis delta virus (HDV) replication: a new model of HDV RNA transcription and replication.

Authors:  L E Modahl; M M Lai
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

8.  Localization of hepatitis delta virus RNA in the nucleus of human cells.

Authors:  C Cunha; J Monjardino; D Cheng; S Krause; M Carmo-Fonseca; D Chang
Journal:  RNA       Date:  1998-06       Impact factor: 4.942

9.  A pseudoknot ribozyme structure is active in vivo and required for hepatitis delta virus RNA replication.

Authors:  K S Jeng; A Daniel; M M Lai
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

10.  Large hepatitis delta antigen is not a suppressor of hepatitis delta virus RNA synthesis once RNA replication is established.

Authors:  Thomas B Macnaughton; Michael M C Lai
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.